Search
Patexia Research
Case number 3:18-cv-14208

VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. SLAYBACK PHARMA, LLC et al > Documents

Date Field Doc. No.Description (Pages)
Jan 28, 2020 18 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER of dismissal without prejudice as to SLAYBACK PHARMA INDIA LLP (18-14208, 19-8218) and SLAYBACK PHARMA, LLC (18-14208, 19-8218) terminated. Signed by Judge Brian R. Martinotti on 01/24/2020. (jmh)
Apr 15, 2019 17 Order (7)
Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh)
Apr 15, 2019 N/A Terminated Case (0)
Docket Text: ***Civil Case Administratively Terminated. (mmh)
Mar 21, 2019 N/A Pretrial Conference - Initial (0)
Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, )
Mar 5, 2019 16 Answer to Counterclaim (17)
Mar 5, 2019 16 Main Document (17)
Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM)
Mar 5, 2019 16 Certificate of Service (2)
Feb 22, 2019 15 Order (5)
Docket Text: ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (mps)
Feb 20, 2019 N/A Update Answer Due Deadline (0)
Docket Text: Clerk`s Text Order - The document [14] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD. has been GRANTED. The answer due date has been set for 3/5/2019. (mps)
Feb 19, 2019 14 Application for Clerk's Order to Ext Answer/Proposed Order (2)
Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kaken Pharmaceutical Co., Ltd... (DENI, WILLIAM)
Jan 28, 2019 13 Corporate Disclosure Statement (aty) (3)
Docket Text: Corporate Disclosure Statement by SLAYBACK PHARMA INDIA LLP, SLAYBACK PHARMA, LLC. (RICHTER, JAMES)
Jan 28, 2019 12 Answer to Complaint (30)
Docket Text: ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by SLAYBACK PHARMA INDIA LLP, SLAYBACK PHARMA, LLC.(RICHTER, JAMES)
Jan 11, 2019 11 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by JAMES S. RICHTER on behalf of SLAYBACK PHARMA INDIA LLP, SLAYBACK PHARMA, LLC (RICHTER, JAMES)
Dec 18, 2018 10 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN)
Dec 11, 2018 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. SLAYBACK PHARMA INDIA LLP waiver sent on 11/28/2018, answer due 2/26/2019. (LOWER, J.)
Dec 11, 2018 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. SLAYBACK PHARMA, LLC waiver sent on 11/28/2018, answer due 1/28/2019. (LOWER, J.)
Dec 5, 2018 7 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.)
Sep 24, 2018 6 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to SLAYBACK PHARMA INDIA LLP, SLAYBACK PHARMA, LLC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh)
Sep 24, 2018 5 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (jmh)
Sep 24, 2018 4 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (jmh)
Sep 24, 2018 N/A Add and Terminate Judges (0)
Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh)
Sep 21, 2018 3 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM)
Sep 21, 2018 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM)
Sep 21, 2018 1 L. Civ. R. 11.2 Certification (2)
Sep 21, 2018 1 Civil Cover Sheet (3)
Sep 21, 2018 1 Exhibit H (11)
Sep 21, 2018 1 Exhibit G (17)
Sep 21, 2018 1 Exhibit F (14)
Sep 21, 2018 1 Exhibit E (11)
Sep 21, 2018 1 Exhibit D (17)
Sep 21, 2018 1 Exhibit C (17)
Sep 21, 2018 1 Exhibit B (16)
Sep 21, 2018 1 Exhibit A (15)
Sep 21, 2018 1 Main Document (25)
Docket Text: COMPLAINT against SLAYBACK PHARMA INDIA LLP, SLAYBACK PHARMA, LLC ( Filing and Admin fee $ 400 receipt number 0312-9042825), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
Sep 21, 2018 1 Complaint (25)
Menu